☆ 4.7 Article

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer

JOURNAL OF GASTROENTEROLOGY (2023)

Related references

Note: Only part of the references are listed.

Letter Oncology

Impact of the COVID-19 pandemic on cancer diagnosis and resection in a COVID-19 low-burden country: Nationwide registration study in Japan

Nobuyuki Horita

EUROPEAN JOURNAL OF CANCER (2022)

Add to Collection

Article Oncology

Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands

Esther Toes-Zoutendijk et al.

Summary: This study assessed the impact of the COVID-19 pandemic on colorectal cancer (CRC) incidence and stage distribution in the Netherlands. The findings showed a significant decrease in CRC incidence during the pandemic, particularly for stage I tumors. However, after gradually resuming screening, the number of CRC diagnoses increased.

EUROPEAN JOURNAL OF CANCER (2022)

Add to Collection

Article Oncology

Impact of two waves of Sars-Cov2 outbreak on the number, clinical presentation, care trajectories and survival of patients newly referred for a colorectal cancer: A French multicentric cohort study from a large group of university hospitals

Emmanuelle Kempf et al.

Summary: This study aimed to assess the indicators of new colorectal cancer patients before and after the beginning of the pandemic in France. The results showed that the SARS-Cov2 pandemic was associated with a decrease in newly diagnosed CRC patients and worse 1-year survival rates, primarily attributed to the infection itself.

INTERNATIONAL JOURNAL OF CANCER (2022)

Add to Collection

Article Surgery

The effect of preoperative body mass index on short-term outcome after esophagectomy for cancer: A nationwide propensity score-matched analysis

Jan A. H. Gooszen et al.

Summary: This study aimed to investigate the relationship between preoperative body mass index and clinical and oncological outcomes of esophageal cancer surgery. The study found that underweight patients are more prone to postoperative complications, highlighting the importance of addressing underweight in the postoperative period.

SURGERY (2022)

Add to Collection

Article Surgery

Impact of the COVID-19 pandemic on surgical care in the Netherlands

Michelle R. de Graaff et al.

Summary: This study found that during the COVID-19 pandemic, surgical procedures in the Netherlands decreased by 13.6%, with no significant increase in adverse outcomes. Non-cancer procedures were most affected, while oncological surgeries had shorter hospital stays.

BRITISH JOURNAL OF SURGERY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database

Marten A. Lantinga et al.

Summary: The COVID-19 lockdown led to a significant reduction in the number of endoscopies performed in Dutch hospitals, with a higher likelihood of detecting cancer during endoscopy. After the lockdown was lifted, endoscopy volumes quickly returned to normal, except for colorectal cancer screening.

ENDOSCOPY (2021)

Add to Collection

Article Health Care Sciences & Services

Concerns, quality of life, access to care and productivity of the general population during the first 8weeks of the coronavirus lockdown in Belgium and the Netherlands

Hanne van Ballegooijen et al.

Summary: A population survey conducted in Belgium and the Netherlands after 8 weeks of coronavirus lockdown showed that a majority of respondents were concerned about their health, many had delayed or cancelled medical care, and productivity was also affected.

BMC HEALTH SERVICES RESEARCH (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Oncology

New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: A persistent and concerning decrease long after the end of the national lockdown

Emmanuelle Kempf et al.

Summary: The spread of SARS-Cov2 led to a substantial decrease in new cancer cases, affecting patients of different age groups and cancer types. This trend may impact clinical outcomes in the coming years.

EUROPEAN JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Safety of Esophageal Cancer Surgery During the First Wave of the COVID-19 Pandemic in Europe: A Multicenter Study

Alexander B. J. Borgstein et al.

Summary: This study found that esophageal cancer surgery during the first wave of the COVID-19 pandemic did not increase the risk of respiratory failure requiring mechanical ventilation or pulmonary complications. With adequate preoperative screening methods, esophageal cancer surgery can be performed safely during the pandemic.

ANNALS OF SURGICAL ONCOLOGY (2021)

Add to Collection

Article Oncology

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

Ben M. Eyck et al.

Summary: The preoperative chemoradiotherapy regimen according to CROSS study has shown to have a long-term overall survival benefit for patients with locally advanced resectable esophageal or junctional cancer, with a stable effect observed up to 10 years of follow-up.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Oncology

Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study

Anouk H. Eijkelboom et al.

Summary: The onset of the COVID-19 pandemic led to a decline in breast cancer incidence in early 2020, prompting rapid adaptations in treatment approaches. Factors such as tumor behavior, treatment modalities, and timing showed significant impact on breast cancer diagnosis and treatment, highlighting the need for further understanding on the effects of treatment delays on patient outcomes.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer

Ben M. Eyck et al.

Summary: The SANO trial compares active surveillance and surgery for patients with cCR to neoadjuvant chemoradiotherapy. Amendments to the study design, eligibility criteria, and study procedures have been made, with the first results expected in late 2023.

TRIALS (2021)

Add to Collection

Article Oncology

Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study)

Maarten C. C. M. Hulshof et al.

Summary: In definitive chemoradiation for esophageal cancer, escalating radiation dose up to 61.6 Gy to the primary tumor did not significantly improve local tumor control compared to 50.4 Gy. The absence of a dose-effect was observed in both adenocarcinoma and squamous cell carcinoma.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Review Oncology

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review

Rachel Riera et al.

Summary: The study identified a high frequency of delays and disruptions in cancer care services globally due to the reduction in service availability caused by the COVID-19 pandemic. Various categories of delays and disruptions were found to impact cancer treatment, diagnosis, and general health services.

JCO GLOBAL ONCOLOGY (2021)

Add to Collection

Editorial Material Surgery

A Snapshot of Elective Oncological Surgery in Italy During COVID-19 Emergency Pearls, Pitfalls, and Perspectives

Guido Torzilli et al.

ANNALS OF SURGERY (2020)

Add to Collection

Editorial Material Oncology

Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands Comment

Avinash G. Dinmohamed et al.

LANCET ONCOLOGY (2020)

Add to Collection

Article Surgery

Surgical Morbidity and Mortality From the Multicenter Randomized Controlled NeoRes II Trial Standard Versus Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy for Esophageal Cancer

Klara Nilsson et al.

ANNALS OF SURGERY (2020)

Add to Collection

Article Oncology

Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study

L. R. van der Werf et al.

EUROPEAN JOURNAL OF CANCER (2018)

Add to Collection

Review Gastroenterology & Hepatology

ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus

Nicholas J. Shaheen et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)

Add to Collection

Article Oncology

Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial

Kazumasa Fujitani et al.

LANCET ONCOLOGY (2016)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries

Maria Jose Domper Arnal et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Add to Collection

Article Surgery

Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer

Joel Shapiro et al.

ANNALS OF SURGERY (2014)

Add to Collection

Article Oncology

Epidemiology and Risk Factors for Gastroesophageal Junction Tumors: Understanding the Rising Incidence of This Disease

Matthew F. Buas et al.

SEMINARS IN RADIATION ONCOLOGY (2013)

Add to Collection

© Peeref 2019-2024. All rights reserved.